Viemed Healthcare, Inc. (NASDAQ:VMD) Short Interest Update

Viemed Healthcare, Inc. (NASDAQ:VMD - Get Free Report) was the recipient of a significant increase in short interest in October. As of October 15th, there was short interest totalling 305,100 shares, an increase of 48.5% from the September 30th total of 205,500 shares. Based on an average trading volume of 122,800 shares, the days-to-cover ratio is presently 2.5 days. Approximately 0.9% of the company's stock are short sold.

Hedge Funds Weigh In On Viemed Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of VMD. Perkins Coie Trust Co purchased a new stake in Viemed Healthcare in the third quarter valued at $73,000. SG Americas Securities LLC acquired a new position in shares of Viemed Healthcare in the 3rd quarter valued at about $89,000. The Manufacturers Life Insurance Company boosted its stake in shares of Viemed Healthcare by 14.7% in the second quarter. The Manufacturers Life Insurance Company now owns 14,918 shares of the company's stock worth $98,000 after buying an additional 1,912 shares during the last quarter. MBB Public Markets I LLC acquired a new stake in Viemed Healthcare during the second quarter worth about $130,000. Finally, Raffles Associates LP raised its position in Viemed Healthcare by 4.3% during the second quarter. Raffles Associates LP now owns 362,691 shares of the company's stock valued at $2,376,000 after acquiring an additional 15,000 shares in the last quarter. Institutional investors and hedge funds own 74.24% of the company's stock.

Viemed Healthcare Stock Performance

Viemed Healthcare stock traded down $0.15 during mid-day trading on Monday, reaching $9.09. 178,867 shares of the company traded hands, compared to its average volume of 145,522. The firm's fifty day moving average is $7.90 and its two-hundred day moving average is $7.44. The company has a market capitalization of $352.96 million, a price-to-earnings ratio of 37.83 and a beta of 1.47. Viemed Healthcare has a fifty-two week low of $5.90 and a fifty-two week high of $10.44. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 1.29.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last issued its earnings results on Wednesday, August 7th. The company reported $0.04 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.07 by ($0.03). The firm had revenue of $54.97 million during the quarter. Viemed Healthcare had a return on equity of 8.23% and a net margin of 4.60%.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.